Combined Mechanical and Pharmacological Thrombolysis for Iliofemoral DVT presenting as Phlegmasia Cerulea Dolens |
||||||||||||
| Andrew M. Bakken M.D. and Mark G. Davies, M.D., Ph.D. | ||||||||||||
| University of Rochester, Rochester, New York 14642 |
||||||||||||
Contact Email: mark_davies@urmc.rochester.edu A 60 yr. old female presented with an acutely swollen, painful, blue-colored leg to the emergency. She stated it felt weaker than the other leg. There was no history of injury deep venous thrombosis or malignancy. On examination the leg was swollen cyanotic and has diminished power and decreased arterial pulses. Duplex imaging and a CT scan in the emergency room demonstrated extensive deep venous thrombosis extending from the popliteal vein to the left iliac vein (Figure 1). A diagnosis of Phlegmasia Cerulea Dolens was made. The patient underwent a venogram from the ipsilateral popliteal approach, which confirmed an extensive iliofemoral DVT. A combined mechanical and chemical thrombolysis intervention was planned. A rheolytic catheter (AngioJet, Possis Medical Inc, Minneapolis, MN) was passed through the clot in a power pulse spray mode (its outflow valve turned off and a 5mg/100ml tPA solution infusate) in orer to locally lyse and mascerate the clot. Thereafter the system was returned to its normal set up and 750mls of solution was used to angiojet the ilio-femoral DVT over five passages of the rheolytic catheter (Figure 2). A 6mm and then a 10mm angioplasty balloon were used to angioplasty the common iliac vein. 80% of clot burden was removed and TIMI-2 flow was restored (Figure 2). The patient's leg was markedly improved after debulking of the clot. An infusion catheter was positioned in the iliac venous system and 1mg/hr of tPA was infused for 18 hrs. On return to the angiography suite, repeat venography showed TIMI-2/3 flow and 90% clot lysis. A significant stenosis was identified in the common iliac vein consistent with the May-Thurner syndrome (Figure 3). A 14mmx40mm Wallstent was placed and post ballooned in position with restoration of TIMI-3 flow and the absence of collateral vein opacification (Figure 3). The final technical result was excellent (Figure 3). The patient made an uneventful recovery. She was placed on oral anticoagulation for 3 months. Hypercoagulation and malignancy screens were negative. At six and twelve months, the patient was asymptomatic and duplex imaging confirmed a patent iliac vein stent and a patent venous system. Endovascular therapy utilizing combined mechanical and chemical thrombolysis is a successful approach for phlegmasia cerulea dolens.
|
||||||||||||